通过社会科学研究加强普遍的艾滋病毒“检测和治疗”方法

AIDS (London, England) Pub Date : 2016-03-07 DOI:10.1097/QAD.0000000000001008

C. Camlin, J. Seeley, L. Viljoen, E. Vernooij, M. Simwinga, Lindsey J Reynolds, R. Reis, R. Plank, J. Orne-Gliemann, N. McGrath, J. Larmarange, G. Hoddinott, Monica Getahun, E. Charlebois, V. Bond

{"title":"通过社会科学研究加强普遍的艾滋病毒“检测和治疗”方法","authors":"C. Camlin, J. Seeley, L. Viljoen, E. Vernooij, M. Simwinga, Lindsey J Reynolds, R. Reis, R. Plank, J. Orne-Gliemann, N. McGrath, J. Larmarange, G. Hoddinott, Monica Getahun, E. Charlebois, V. Bond","doi":"10.1097/QAD.0000000000001008","DOIUrl":null,"url":null,"abstract":"The recent publication of new WHO guidelines, including a call for antiretroviral therapy for everyone diagnosed with HIV regardless of CD4+ cell count and preexposure prophylaxis for people at substantial risk of HIV infection [1], marks an important moment for taking stock of what will be needed to take biomedical HIV prevention approaches to scale, and sustain them. As the author of a recent editorial in The Lancet [2] observes, these guidelines are ‘welcome but ambitious. […] No studies exist that address how such a strategy can be executed on a global scale’ (p. 1420).","PeriodicalId":355297,"journal":{"name":"AIDS (London, England)","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"20","resultStr":"{\"title\":\"Strengthening universal HIV ‘test-and-treat’ approaches with social science research\",\"authors\":\"C. Camlin, J. Seeley, L. Viljoen, E. Vernooij, M. Simwinga, Lindsey J Reynolds, R. Reis, R. Plank, J. Orne-Gliemann, N. McGrath, J. Larmarange, G. Hoddinott, Monica Getahun, E. Charlebois, V. Bond\",\"doi\":\"10.1097/QAD.0000000000001008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The recent publication of new WHO guidelines, including a call for antiretroviral therapy for everyone diagnosed with HIV regardless of CD4+ cell count and preexposure prophylaxis for people at substantial risk of HIV infection [1], marks an important moment for taking stock of what will be needed to take biomedical HIV prevention approaches to scale, and sustain them. As the author of a recent editorial in The Lancet [2] observes, these guidelines are ‘welcome but ambitious. […] No studies exist that address how such a strategy can be executed on a global scale’ (p. 1420).\",\"PeriodicalId\":355297,\"journal\":{\"name\":\"AIDS (London, England)\",\"volume\":\"9 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"20\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS (London, England)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/QAD.0000000000001008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000001008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 20

摘要

最近发布的世卫组织新指南，包括呼吁对所有被诊断患有艾滋病毒的人进行抗逆转录病毒治疗，无论其CD4+细胞计数如何，以及对面临重大艾滋病毒感染风险的人进行暴露前预防[1]，标志着一个重要的时刻，可以评估将需要哪些措施来大规模采取并维持艾滋病毒生物医学预防方法。正如《柳叶刀》最近一篇社论的作者[2]所观察到的那样，这些指导方针是“受欢迎的，但雄心勃勃”。[…]没有研究表明如何在全球范围内执行这样的战略”(第1420页)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Strengthening universal HIV ‘test-and-treat’ approaches with social science research

The recent publication of new WHO guidelines, including a call for antiretroviral therapy for everyone diagnosed with HIV regardless of CD4+ cell count and preexposure prophylaxis for people at substantial risk of HIV infection [1], marks an important moment for taking stock of what will be needed to take biomedical HIV prevention approaches to scale, and sustain them. As the author of a recent editorial in The Lancet [2] observes, these guidelines are ‘welcome but ambitious. […] No studies exist that address how such a strategy can be executed on a global scale’ (p. 1420).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

AIDS (London, England)

自引率

0.00%

发文量